Advertisement

Emerging Treatments for Classical Myeloproliferative Neoplasms

The authors illustrate the current landscape of novel therapies that are under evaluation for patients with myeloproliferative neoplasms on the basis of current guidelines, patient risk stratification criteria, and previous experience.

 Blood

click me